CRYSTAL HOLDEN: Open Payments
NPI 1922659531 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 44 payments from 12 companies in 2025. Trend: 2023 $520 · 2024 $397 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $172 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| ABBVIE INC. | 4 | $94 |
| Sumitomo Pharma America, Inc. | 5 | $81 |
| PFIZER INC. | 3 | $69 |
| Exact Sciences Corporation | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Astellas Pharma US Inc | 2 | $36 |
| Abbott Laboratories | 1 | $24 |
| Amgen Inc. | 1 | $22 |
Products named: Wegovy, GEMTESA, NURTEC ODT, QULIPTA, AIRSUPRA, MOUNJARO, Rybelsus, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
